Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 726 articles:
HTML format



Single Articles


    May 2020
  1. JAZINIZADEH F, Adachi JD, Quenneville CE
    Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans.
    Osteoporos Int. 2020 May 15. pii: 10.1007/s00198-020-05444.
    PubMed     Abstract available


  2. SHOJAA M, von Stengel S, Kohl M, Schoene D, et al
    Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a systematic review and meta-analysis with special emphasis on exercise parameters.
    Osteoporos Int. 2020 May 12. pii: 10.1007/s00198-020-05441.
    PubMed     Abstract available


  3. KWON YE, Choi HY, Oh HJ, Ahn SY, et al
    Vertebral fracture is associated with myocardial infarction in incident hemodialysis patients: a Korean nationwide population-based study.
    Osteoporos Int. 2020 May 11. pii: 10.1007/s00198-020-05423.
    PubMed     Abstract available


  4. BASSATNE A, Harb H, Jaafar B, Romanos J, et al
    Disease burden of osteoporosis and other non-communicable diseases in Lebanon.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05433.
    PubMed     Abstract available


  5. KYVERNITAKIS I, Kostev K, Thomasius F, Stumpf U, et al
    Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05437.
    PubMed     Abstract available


  6. SOTO-SUBIABRE M, Mayoral V, Fiter J, Valencia L, et al
    Vertebral fracture: clinical presentation and severity are linked to fracture risk factors.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05425.
    PubMed    


  7. AUL AJ, Dudenkov DV, Mara KC, Juhn YJ, et al
    The relationship of 25-hydroxyvitamin D values and risk of fracture: a population-based retrospective cohort study.
    Osteoporos Int. 2020 May 6. pii: 10.1007/s00198-020-05436.
    PubMed     Abstract available


  8. CAI G, Keen HI, Host LV, Aitken D, et al
    Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON Pivotal Fracture Trial.
    Osteoporos Int. 2020 May 2. pii: 10.1007/s00198-020-05430.
    PubMed     Abstract available


  9. JALILI C, Kazemi M, Taheri E, Mohammadi H, et al
    Exposure to heavy metals and the risk of osteopenia or osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 May 2. pii: 10.1007/s00198-020-05429.
    PubMed     Abstract available


  10. CORNELISSEN D, de Kunder S, Si L, Reginster JY, et al
    Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review.
    Osteoporos Int. 2020 May 1. pii: 10.1007/s00198-020-05378.
    PubMed     Abstract available


    April 2020
  11. GIRGIS CM, Clifton-Bligh RJ
    Osteoporosis in the age of COVID-19.
    Osteoporos Int. 2020 Apr 28. pii: 10.1007/s00198-020-05413.
    PubMed     Abstract available


  12. JIN H, Ma X, Liu Y, Liu M, et al
    Back pain from painful osteoporotic vertebral fractures: discrepancy between the actual fracture location and the location suggested by patient-reported pain or physical examination findings.
    Osteoporos Int. 2020 Apr 28. pii: 10.1007/s00198-020-05434.
    PubMed     Abstract available


  13. STANGHELLE B, Bentzen H, Giangregorio L, Pripp AH, et al
    Correction to: Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
    Osteoporos Int. 2020 Apr 27. pii: 10.1007/s00198-020-05398.
    PubMed     Abstract available


  14. KEAVENY TM, Clarke BL, Cosman F, Orwoll ES, et al
    Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis.
    Osteoporos Int. 2020 Apr 26. pii: 10.1007/s00198-020-05384.
    PubMed     Abstract available


  15. LINTON DN, Porteous J, Eatson H, Chepesiuk R, et al
    Educational booklet reinforces knowledge of osteoporosis and influences intentions to improve bone health in previously diagnosed and treated patients.
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05392.
    PubMed     Abstract available


  16. MCCLOSKEY E, Harvey N, Johansson H, Lorentzon M, et al
    Screening for high fracture risk.
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05416.
    PubMed    


  17. MERLIJN T, Swart KMA, Netelenbos JC, Elders PJM, et al
    Reply to "Screening for high fracture risk".
    Osteoporos Int. 2020 Apr 24. pii: 10.1007/s00198-020-05417.
    PubMed    


  18. ZHANG H, Liu L, Ni JJ, Wei XT, et al
    Pleiotropic loci underlying bone mineral density and bone size identified by a bivariate genome-wide association analysis.
    Osteoporos Int. 2020 Apr 20. pii: 10.1007/s00198-020-05389.
    PubMed     Abstract available


  19. SHIN YH, Hong WK, Kim J, Gong HS, et al
    Osteoporosis care after distal radius fracture reduces subsequent hip or spine fractures: a 4-year longitudinal study.
    Osteoporos Int. 2020 Apr 16. pii: 10.1007/s00198-020-05410.
    PubMed     Abstract available


  20. WANG Y, Zhao R, Gu Z, Dong C, et al
    Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Apr 14. pii: 10.1007/s00198-020-05360.
    PubMed     Abstract available


  21. CAVALIER E, Lukas P, Bottani M, Aarsand AK, et al
    European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates of beta-isomerized C-terminal telopeptide of type I collagen (beta-CTX), N-terminal propeptide of type I collagen (PINP), osteocalcin, intact fib
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05362.
    PubMed     Abstract available


  22. SCHOEB M, Malgo F, Peeters JJM, Winter EM, et al
    Treatments of osteoporosis increase bone material strength index in patients with low bone mass.
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05375.
    PubMed     Abstract available


  23. JAVAID MK, Sami A, Lems W, Mitchell P, et al
    A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fract
    Osteoporos Int. 2020 Apr 8. pii: 10.1007/s00198-020-05377.
    PubMed     Abstract available


  24. ABOUDIAB M, Grados F, Batteux B, Henry-Desailly I, et al
    Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture.
    Osteoporos Int. 2020 Apr 7. pii: 10.1007/s00198-020-05400.
    PubMed     Abstract available


  25. SORESKOG E, Borgstrom F, Shepstone L, Clarke S, et al
    Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study.
    Osteoporos Int. 2020 Apr 1. pii: 10.1007/s00198-020-05372.
    PubMed     Abstract available


  26. THOMPSON MJW, Jones G, Balogun S, Aitken DA, et al
    Constitutive melanin density is associated with prevalent and short-term, but not long-term, incident fracture risk in older Caucasian adults.
    Osteoporos Int. 2020 Apr 1. pii: 10.1007/s00198-020-05304.
    PubMed     Abstract available


    March 2020
  27. STROM O, Lauppe R, Ljunggren O, Spangeus A, et al
    Real-world effectiveness of osteoporosis treatment in the oldest old.
    Osteoporos Int. 2020 Mar 30. pii: 10.1007/s00198-020-05380.
    PubMed     Abstract available


  28. WATTS NB, Hattersley G, Fitzpatrick LA, Wang Y, et al
    Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2020 Mar 30. pii: 10.1007/s00198-020-05349.
    PubMed     Abstract available


  29. PREMAOR MO, Compston JE
    People living with HIV and fracture risk.
    Osteoporos Int. 2020 Mar 23. pii: 10.1007/s00198-020-05350.
    PubMed     Abstract available


  30. MCKEE H, Ioannidis G, Lau A, Treleaven D, et al
    Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    Osteoporos Int. 2020 Mar 18. pii: 10.1007/s00198-020-05381.
    PubMed     Abstract available


  31. COLANGELO L, Pepe J, Nieddu L, Sonato C, et al
    Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia.
    Osteoporos Int. 2020 Mar 17. pii: 10.1007/s00198-020-05369.
    PubMed     Abstract available


  32. PASCO JA, Mohebbi M, Tembo MC, Holloway-Kew KL, et al
    Repurposing a fracture risk calculator (FRAX) as a screening tool for women at risk for sarcopenia.
    Osteoporos Int. 2020 Mar 17. pii: 10.1007/s00198-020-05376.
    PubMed     Abstract available


  33. LESLIE WD, Schousboe JT, Morin SN, Martineau P, et al
    Fracture risk following high-trauma versus low-trauma fracture: a registry-based cohort study.
    Osteoporos Int. 2020 Mar 16. pii: 10.1007/s00198-019-05274.
    PubMed     Abstract available


  34. ZHOU J, Xue Y
    Depression, falls, and osteoporotic fractures.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05347.
    PubMed    


  35. OKANO I, Jones C, Salzmann SN, Miller CO, et al
    Postoperative decrease of regional volumetric bone mineral density measured by quantitative computed tomography after lumbar fusion surgery in adjacent vertebrae.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05367.
    PubMed     Abstract available


  36. PARULEKAR AD, Wang T, Li GW, Hoang V, et al
    Pectoralis muscle area is associated with bone mineral density and lung function in lung transplant candidates.
    Osteoporos Int. 2020 Mar 13. pii: 10.1007/s00198-020-05373.
    PubMed     Abstract available


  37. CUI R, Sun SQ, Zhong N, Xu MX, et al
    The relationship between atherosclerosis and bone mineral density in patients with type 2 diabetes depends on vascular calcifications and sex.
    Osteoporos Int. 2020 Mar 10. pii: 10.1007/s00198-020-05374.
    PubMed     Abstract available


  38. KIM CH, Kim JW
    Letter to the editor about the article "Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment".
    Osteoporos Int. 2020 Mar 6. pii: 10.1007/s00198-020-05354.
    PubMed    


  39. ICONARU L, Smeys C, Baleanu F, Kinnard V, et al
    Osteoporosis treatment gap in a prospective cohort of volunteer women.
    Osteoporos Int. 2020 Mar 3. pii: 10.1007/s00198-020-05339.
    PubMed     Abstract available


    February 2020
  40. CHAO CT, Wang J, Huang JW, Chan DC, et al
    Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.
    Osteoporos Int. 2020 Feb 27. pii: 10.1007/s00198-020-05353.
    PubMed     Abstract available


  41. ZHOU J, Huo X, Xue Y
    Comments on Min et al.: Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study.
    Osteoporos Int. 2020 Feb 22. pii: 10.1007/s00198-020-05355.
    PubMed    


  42. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2020 Feb 18. pii: 10.1007/s00198-020-05303.
    PubMed     Abstract available


  43. KANIS JA, Harvey NC, McCloskey E, Bruyere O, et al
    Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
    Osteoporos Int. 2020 Feb 17. pii: 10.1007/s00198-020-05297.
    PubMed     Abstract available


  44. LEWIECKI EM, Chastek B, Sundquist K, Williams SA, et al
    Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017.
    Osteoporos Int. 2020 Feb 15. pii: 10.1007/s00198-020-05334.
    PubMed     Abstract available


  45. TAKAHASHI S, Hoshino M, Takayama K, Sasaoka R, et al
    The natural course of the paravertebral muscles after the onset of osteoporotic vertebral fracture.
    Osteoporos Int. 2020 Feb 14. pii: 10.1007/s00198-020-05338.
    PubMed     Abstract available


  46. DE BOT RTAL, Veldman HD, Witlox AM, van Rhijn LW, et al
    Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk.
    Osteoporos Int. 2020 Feb 10. pii: 10.1007/s00198-019-05252.
    PubMed     Abstract available


  47. PAPAIOANNOU A, Adachi JD, Berger C, Jiang Y, et al
    Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2020 Feb 7. pii: 10.1007/s00198-020-05330.
    PubMed     Abstract available


  48. CHOI D, Choi S, Chang J, Park SM, et al
    Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
    Osteoporos Int. 2020 Feb 7. pii: 10.1007/s00198-020-05327.
    PubMed     Abstract available


  49. NAYAK S, Greenspan SL
    Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis.
    Osteoporos Int. 2020 Feb 4. pii: 10.1007/s00198-019-05258.
    PubMed     Abstract available


  50. ADAMI G, Saag KG, Mudano AS, Rahn EJ, et al
    Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.
    Osteoporos Int. 2020 Feb 4. pii: 10.1007/s00198-020-05312.
    PubMed     Abstract available


  51. LESLIE WD, Schousboe JT, Morin SN, Martineau P, et al
    Measured height loss predicts incident clinical fractures independently from FRAX: a registry-based cohort study.
    Osteoporos Int. 2020 Feb 3. pii: 10.1007/s00198-020-05313.
    PubMed     Abstract available


  52. WONGTRAKUL W, Charoenngam N, Ungprasert P
    The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Feb 1. pii: 10.1007/s00198-020-05318.
    PubMed     Abstract available


  53. ISAKSSON S, Bogefors K, Akesson K, Ora I, et al
    Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors.
    Osteoporos Int. 2020 Feb 1. pii: 10.1007/s00198-020-05285.
    PubMed     Abstract available


    January 2020
  54. DING LL, Wen F, Wang H, Wang DH, et al
    Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data.
    Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-019-05183.
    PubMed     Abstract available


  55. MARTIN J, Viprey M, Castagne B, Merle B, et al
    Interventions to improve osteoporosis care: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-020-05308.
    PubMed     Abstract available


  56. YOSHIDA T, Kinoshita H, Taniguchi H, Yanishi M, et al
    A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosum
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-019-05271.
    PubMed     Abstract available


  57. PAGGIOSI MA, Debono M, Walsh JS, Peel NFA, et al
    Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.
    Osteoporos Int. 2020 Jan 28. pii: 10.1007/s00198-020-05317.
    PubMed     Abstract available


  58. CONDURACHE CI, Chiu S, Chotiyarnwong P, Johansson H, et al
    Screening for high hip fracture risk does not impact on falls risk: a post hoc analysis from the SCOOP study.
    Osteoporos Int. 2020 Jan 20. pii: 10.1007/s00198-019-05270.
    PubMed     Abstract available


  59. ADAMI G, Rossini M, Fassio A, Viapiana O, et al
    Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures.
    Osteoporos Int. 2020 Jan 17. pii: 10.1007/s00198-020-05302.
    PubMed    


  60. STANGHELLE B, Bentzen H, Giangregorio L, Pripp AH, et al
    Effects of a resistance and balance exercise programme on physical fitness, health-related quality of life and fear of falling in older women with osteoporosis and vertebral fracture: a randomized controlled trial.
    Osteoporos Int. 2020 Jan 10. pii: 10.1007/s00198-019-05256.
    PubMed     Abstract available


  61. SIMON D, Haschka J, Muschitz C, Kocijan A, et al
    Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.
    Osteoporos Int. 2020 Jan 10. pii: 10.1007/s00198-019-05160.
    PubMed     Abstract available


  62. MCKEE H, Ioannidis G, Lau A, Treleaven D, et al
    Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
    Osteoporos Int. 2020 Jan 3. pii: 10.1007/s00198-019-05267.
    PubMed     Abstract available


  63. BOUXSEIN ML, Zysset P, Gluer CC, McClung M, et al
    Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk.
    Osteoporos Int. 2020 Jan 3. pii: 10.1007/s00198-019-05195.
    PubMed     Abstract available


  64. IERVOLINO LL, Ferraz-de-Souza B, Martin RM, Costa FC, et al
    Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years.
    Osteoporos Int. 2020 Jan 2. pii: 10.1007/s00198-019-05268.
    PubMed     Abstract available


    December 2019
  65. KO Y, Lee G, Kim B, Park M, et al
    Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.
    Osteoporos Int. 2019 Dec 20. pii: 10.1007/s00198-019-05200.
    PubMed     Abstract available


  66. LANYAN A, Marques-Vidal P, Gonzalez-Rodriguez E, Hans D, et al
    Postmenopausal women with osteoporosis consume high amounts of vegetables but insufficient dairy products and calcium to benefit from their virtues: the CoLaus/OsteoLaus cohort.
    Osteoporos Int. 2019 Dec 17. pii: 10.1007/s00198-019-05225.
    PubMed     Abstract available


  67. LOPEZ-OLIVO MA, des Bordes JKA, Lin H, Rizvi T, et al
    Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial.
    Osteoporos Int. 2019 Dec 16. pii: 10.1007/s00198-019-05210.
    PubMed     Abstract available


  68. MORIN SN, Djekic-Ivankovic M, Funnell L, Giangregorio L, et al
    Patient engagement in clinical guidelines development: input from > 1000 members of the Canadian Osteoporosis Patient Network.
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05248.
    PubMed     Abstract available


  69. TSVETOV G, Amitai O, Shochat T, Shimon I, et al
    Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05261.
    PubMed     Abstract available


  70. MERLIJN T, Swart KMA, van der Horst HE, Netelenbos JC, et al
    Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05226.
    PubMed     Abstract available


  71. GAI QY, Lv H, Li YP, Fu QM, et al
    Education intervention for older adults with osteoporosis: a systematic review.
    Osteoporos Int. 2019 Dec 11. pii: 10.1007/s00198-019-05166.
    PubMed     Abstract available


  72. PRINS JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, et al
    Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study.
    Osteoporos Int. 2019 Dec 11. pii: 10.1007/s00198-019-05219.
    PubMed     Abstract available


  73. ADAS-OKUMA MG, Maeda SS, Gazzotti MR, Roco CM, et al
    COPD as an independent risk factor for osteoporosis and fractures.
    Osteoporos Int. 2019 Dec 6. pii: 10.1007/s00198-019-05235.
    PubMed     Abstract available


  74. HOWE JG, Hill RS, Stroncek JD, Shaul JL, et al
    Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study.
    Osteoporos Int. 2019 Dec 4. pii: 10.1007/s00198-019-05230.
    PubMed     Abstract available


  75. NASOMYONT N, Hornung LN, Wasserman H
    Intravenous bisphosphonate therapy in children with spinal muscular atrophy.
    Osteoporos Int. 2019 Dec 2. pii: 10.1007/s00198-019-05227.
    PubMed     Abstract available


  76. XIAO X, Wu Q
    Association between a literature-based genetic risk score and bone mineral density of African American women in Women Health Initiative Study.
    Osteoporos Int. 2019 Dec 1. pii: 10.1007/s00198-019-05244.
    PubMed     Abstract available


    November 2019
  77. O'SULLIVAN LM, Allison H, Parle EE, Schiavi J, et al
    Secondary alterations in bone mineralisation and trabecular thickening occur after long-term estrogen deficiency in ovariectomised rat tibiae, which do not coincide with initial rapid bone loss.
    Osteoporos Int. 2019 Nov 30. pii: 10.1007/s00198-019-05239.
    PubMed     Abstract available


  78. MILLER PD, Pannacciulli N, Malouf-Sierra J, Singer A, et al
    Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
    Osteoporos Int. 2019 Nov 28. pii: 10.1007/s00198-019-05233.
    PubMed     Abstract available


  79. OH HJ, Yoon BH, Ha YC, Suh DC, et al
    The change of bone mineral density and bone metabolism after gastrectomy for gastric cancer: a meta-analysis.
    Osteoporos Int. 2019 Nov 27. pii: 10.1007/s00198-019-05220.
    PubMed     Abstract available


  80. VAN DORT MJ, Driessen JHM, Geusens P, Romme EAPM, et al
    Association between vertebral fractures and coronary artery calcification in current and former smokers in the ECLIPSE cohort.
    Osteoporos Int. 2019 Nov 25. pii: 10.1007/s00198-019-05218.
    PubMed     Abstract available


  81. PALCU P, Munce S, Jaglal SB, Allin S, et al
    Understanding patient experiences and challenges to osteoporosis care delivered virtually by telemedicine: a mixed methods study.
    Osteoporos Int. 2019 Nov 23. pii: 10.1007/s00198-019-05182.
    PubMed     Abstract available


  82. MORLEY J, Moayyeri A, Ali L, Taylor A, et al
    Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.
    Osteoporos Int. 2019 Nov 22. pii: 10.1007/s00198-019-05228.
    PubMed     Abstract available


  83. CUI L, He T, Jiang Y, Li M, et al
    Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05173.
    PubMed     Abstract available


  84. BORGEN TT, Bjornerem A, Solberg LB, Andreasen C, et al
    Determinants of trabecular bone score and prevalent vertebral fractures in women with fragility fractures: a cross-sectional sub-study of NoFRACT.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05215.
    PubMed     Abstract available


  85. MALMGREN L, McGuigan FE, Christensson A, Akesson KE, et al
    Kidney function and its association to imminent, short- and long-term fracture risk-a longitudinal study in older women.
    Osteoporos Int. 2019 Nov 21. pii: 10.1007/s00198-019-05152.
    PubMed     Abstract available


  86. HOFF M, Skovlund E, Skurtveit S, Meyer HE, et al
    Proton pump inhibitors and fracture risk. The HUNT study, Norway.
    Osteoporos Int. 2019 Nov 18. pii: 10.1007/s00198-019-05206.
    PubMed     Abstract available


  87. LOFFLER MT, Sollmann N, Mei K, Valentinitsch A, et al
    X-ray-based quantitative osteoporosis imaging at the spine.
    Osteoporos Int. 2019 Nov 14. pii: 10.1007/s00198-019-05212.
    PubMed     Abstract available


  88. JANSZ TT, Goto NA, van Ballegooijen AJ, Willems HC, et al
    The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.
    Osteoporos Int. 2019 Nov 14. pii: 10.1007/s00198-019-05187.
    PubMed     Abstract available


  89. LEE K, Lim S, Park H, Woo HY, et al
    Subclinical thyroid dysfunction, bone mineral density, and osteoporosis in a middle-aged Korean population.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05205.
    PubMed     Abstract available


  90. KANIS JA, Harvey NC, McCloskey E, Bruyere O, et al
    Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05176.
    PubMed     Abstract available


  91. JIANG H, Robinson DL, Yates CJ, Lee PVS, et al
    Peripheral quantitative computed tomography (pQCT)-based finite element analysis provides enhanced diagnostic performance in identifying non-vertebral fracture patients compared with dual-energy X-ray absorptiometry.
    Osteoporos Int. 2019 Nov 13. pii: 10.1007/s00198-019-05213.
    PubMed     Abstract available


  92. BARKER KL, Newman M, Stallard N, Leal J, et al
    Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial).
    Osteoporos Int. 2019 Nov 12. pii: 10.1007/s00198-019-05133.
    PubMed     Abstract available


  93. WANG Y, Yu S, Hsu C, Tsai C, et al
    Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
    Osteoporos Int. 2019 Nov 6. pii: 10.1007/s00198-019-05201.
    PubMed     Abstract available


  94. MINISOLA S, Colangelo L, Cipriani C, Pepe J, et al
    FGF 23 and trabecular microarchitecture.
    Osteoporos Int. 2019;30:2357.
    PubMed    


  95. RUPP T, Amling M, Rolvien T
    FGF23 and bone microarchitecture.
    Osteoporos Int. 2019;30:2359.
    PubMed    


    October 2019
  96. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2019 Oct 31. pii: 10.1007/s00198-019-05184.
    PubMed     Abstract available


  97. HALLIT S, El Hage C, Hajj A, Salameh P, et al
    Construction and validation of the Lebanese Osteoporosis Knowledge Scale among a representative sample of Lebanese women.
    Osteoporos Int. 2019 Oct 30. pii: 10.1007/s00198-019-05192.
    PubMed     Abstract available


  98. ALARKAWI D, Bliuc D, Tran T, Ahmed LA, et al
    Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromso Study.
    Osteoporos Int. 2019 Oct 26. pii: 10.1007/s00198-019-05174.
    PubMed     Abstract available


  99. SOGAARD AJ, Magnus JH, Bjornerem A, Holvik K, et al
    Grip strength in men and women aged 50-79 years is associated with non-vertebral osteoporotic fracture during 15 years follow-up: The Tromso Study 1994-1995.
    Osteoporos Int. 2019 Oct 25. pii: 10.1007/s00198-019-05191.
    PubMed     Abstract available


  100. LESLIE WD
    Bisphosphonates and lower mortality risk: when it sounds to be good to be true ....
    Osteoporos Int. 2019 Oct 19. pii: 10.1007/s00198-019-05157.
    PubMed    


  101. KENDLER DL, Bone HG, Massari F, Gielen E, et al
    Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
    Osteoporos Int. 2019 Oct 18. pii: 10.1007/s00198-019-05146.
    PubMed     Abstract available


  102. ANAGNOSTIS P, Lambrinoudaki I, Kenanidis E, Potoupnis M, et al
    Drug holidays in osteoporosis treatment: mind the gaps!
    Osteoporos Int. 2019 Oct 15. pii: 10.1007/s00198-019-05027.
    PubMed    


  103. NAYAK S, Greenspan SL
    Bisphosphonate drug holidays.
    Osteoporos Int. 2019 Oct 15. pii: 10.1007/s00198-019-05107.
    PubMed    


  104. PARSONS CM, Harvey N, Shepstone L, Kanis JA, et al
    Systematic screening using FRAX((R)) leads to increased use of, and adherence to, anti-osteoporosis medications: an analysis of the UK SCOOP trial.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05142.
    PubMed     Abstract available


  105. CORNELISSEN D, Boonen A, Bours S, Evers S, et al
    Understanding patients' preferences for osteoporosis treatment: the impact of patients' characteristics on subgroups and latent classes.
    Osteoporos Int. 2019 Oct 12. pii: 10.1007/s00198-019-05154.
    PubMed     Abstract available


  106. EBELING PR, Cicuttini F, Scott D, Jones G, et al
    Promoting mobility and healthy aging in men: a narrative review.
    Osteoporos Int. 2019;30:1911-1922.
    PubMed     Abstract available


  107. CUI Y, Lix LM, Yang S, Morin SN, et al
    A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015.
    Osteoporos Int. 2019;30:2119-2127.
    PubMed     Abstract available


    September 2019
  108. LO JC, Grimsrud CD, Ott SM, Chandra M, et al
    Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.
    Osteoporos Int. 2019 Sep 25. pii: 10.1007/s00198-019-05112.
    PubMed     Abstract available


  109. WANG WF, Lin CW, Xie CN, Liu HT, et al
    The association between sarcopenia and osteoporotic vertebral compression refractures.
    Osteoporos Int. 2019 Sep 3. pii: 10.1007/s00198-019-05144.
    PubMed     Abstract available


  110. WANG YXJ, Che-Nordin N, Deng M, Griffith JF, et al
    Elderly males with or without existing osteoporotic vertebral fracture have much lower future vertebral fracture risk than elderly females: the MrOS (Hong Kong) year-4 follow-up spine radiograph study.
    Osteoporos Int. 2019 Sep 2. pii: 10.1007/s00198-019-05136.
    PubMed     Abstract available


  111. LIU Y, Li Z, Arioka M, Wang L, et al
    WNT3A accelerates delayed alveolar bone repair in ovariectomized mice.
    Osteoporos Int. 2019;30:1873-1885.
    PubMed     Abstract available


  112. VAN MAREN MA, Wyers CE, Driessen JHM, Visser JV, et al
    Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program.
    Osteoporos Int. 2019;30:1837-1844.
    PubMed     Abstract available


  113. BAN JK, Hao BB, McCarthy L, Guilcher SJT, et al
    Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Osteoporos Int. 2019;30:1865-1872.
    PubMed     Abstract available


  114. LIU D, Chen L, Dong S, Peng Z, et al
    Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.
    Osteoporos Int. 2019;30:1807-1815.
    PubMed     Abstract available


    August 2019
  115. PNG MA, Mohan PC, Koh JSB, Howe CY, et al
    Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Osteoporos Int. 2019 Aug 21. pii: 10.1007/s00198-019-05067.
    PubMed     Abstract available


  116. ZHANG HY, Weng HL, Li M, Zhang J, et al
    Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
    Osteoporos Int. 2019 Aug 19. pii: 10.1007/s00198-019-05131.
    PubMed     Abstract available


  117. MIN HK, Ahn JH, Ha KY, Kim YH, et al
    Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study.
    Osteoporos Int. 2019 Aug 17. pii: 10.1007/s00198-019-05125.
    PubMed     Abstract available


  118. ABTAHI S, Driessen JHM, Vestergaard P, van den Bergh J, et al
    Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010.
    Osteoporos Int. 2019 Aug 15. pii: 10.1007/s00198-019-05109.
    PubMed     Abstract available


  119. LE B, Ray C, Gonzalez B, Miskevics S, et al
    Laboratory evaluation of secondary causes of bone loss in Veterans with spinal cord injury and disorders.
    Osteoporos Int. 2019 Aug 13. pii: 10.1007/s00198-019-05089.
    PubMed     Abstract available


  120. SUGIMOTO T, Shiraki M, Fukunaga M, Kishimoto H, et al
    Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study.
    Osteoporos Int. 2019 Aug 8. pii: 10.1007/s00198-019-05111.
    PubMed     Abstract available


  121. HILIGSMANN M, Cornelissen D, Vrijens B, Abrahamsen B, et al
    Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskel
    Osteoporos Int. 2019 Aug 7. pii: 10.1007/s00198-019-05104.
    PubMed     Abstract available


  122. LOU S, Shi X, Zhang X, Lyu H, et al
    Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2019 Aug 3. pii: 10.1007/s00198-019-05101.
    PubMed     Abstract available


  123. HARRIS AM, Lee AR, Wong SC
    Systematic review of the effects of bisphosphonates on bone density and fracture incidence in childhood acute lymphoblastic leukaemia.
    Osteoporos Int. 2019 Aug 3. pii: 10.1007/s00198-019-05082.
    PubMed     Abstract available


  124. HEIDARI ME
    Letter to the Editor about the article "A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk".
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05113.
    PubMed    


  125. LU JX, Pan H, Hu XQ, Huang ZW, et al
    Effects of milk powder intervention on bone mineral density and indicators related to bone metabolism in Chinese adolescents.
    Osteoporos Int. 2019 Aug 2. pii: 10.1007/s00198-019-05105.
    PubMed     Abstract available


  126. KHASHAYAR P, Keshtkar A, Ostovar A, Larijani B, et al
    FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Osteoporos Int. 2019 Aug 1. pii: 10.1007/s00198-019-05078.
    PubMed     Abstract available


  127. PEPE J, Cipriani C, Cecchetti V, Ferrara C, et al
    Patients' reasons for adhering to long-term alendronate therapy.
    Osteoporos Int. 2019;30:1627-1634.
    PubMed     Abstract available


    July 2019
  128. BERGMAN J, Nordstrom A, Hommel A, Kivipelto M, et al
    Bisphosphonates and mortality: confounding in observational studies?
    Osteoporos Int. 2019 Jul 31. pii: 10.1007/s00198-019-05097.
    PubMed     Abstract available


  129. HOLLOWAY-KEW KL, Marijanovic N, De Abreu LLF, Sajjad MA, et al
    Bone mineral density in diabetes and impaired fasting glucose.
    Osteoporos Int. 2019 Jul 31. pii: 10.1007/s00198-019-05108.
    PubMed     Abstract available


  130. NORDSTROM P, Nordstrom A
    Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort.
    Osteoporos Int. 2019 Jul 30. pii: 10.1007/s00198-019-05085.
    PubMed     Abstract available


  131. HOLLOWAY-KEW KL, Zhang Y, Betson AG, Anderson KB, et al
    How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
    Osteoporos Int. 2019 Jul 18. pii: 10.1007/s00198-019-05088.
    PubMed     Abstract available


  132. HAYES KN, Ban JK, Athanasiadis G, Burden AM, et al
    Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05061.
    PubMed     Abstract available


  133. KANTEREWICZ E, Puigoriol E, Rodriguez Cros JR, Peris P, et al
    Correction to: Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05050.
    PubMed     Abstract available


  134. VRANKEN L, Wyers CE, van Rietbergen B, Driessen JHM, et al
    The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service.
    Osteoporos Int. 2019 Jul 17. pii: 10.1007/s00198-019-05081.
    PubMed     Abstract available


  135. JEPSEN DB, Ryg J, Hansen S, Jorgensen NR, et al
    The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial.
    Osteoporos Int. 2019 Jul 15. pii: 10.1007/s00198-019-05029.
    PubMed     Abstract available


  136. FUZZELL LN, Richards MJ, Fraenkel L, Stark SL, et al
    What information can the lay public find about osteoporosis treatment? A descriptive study coding the content and quality of bisphosphonate information on the internet.
    Osteoporos Int. 2019 Jul 11. pii: 10.1007/s00198-019-05008.
    PubMed     Abstract available


  137. PFLIMLIN A, Gournay A, Delabriere I, Chantelot C, et al
    Correction to: Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
    Osteoporos Int. 2019 Jul 8. pii: 10.1007/s00198-019-05075.
    PubMed     Abstract available


  138. SVEDBOM A, Hadji P, Hernlund E, Thoren R, et al
    Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.
    Osteoporos Int. 2019 Jul 3. pii: 10.1007/s00198-019-05064.
    PubMed     Abstract available



  139. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Author index.
    Osteoporos Int. 2019;30.
    PubMed    



  140. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Satellite Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  141. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Posters Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  142. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  143. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Meet-the-Experts Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  144. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF-SFR-GRIO Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  145. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  146. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  147. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF USA Symposium Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  148. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-IOF-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging Symposium Abstracts (ESCEO-IOF-WHO CC).
    Osteoporos Int. 2019;30.
    PubMed    



  149. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Ageing Symposium Abstracts (ESCEO-WHO CC).
    Osteoporos Int. 2019;30.
    PubMed    



  150. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): ESCEO Symposia Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  151. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Oral Communications Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  152. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Plenary Lectures Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  153. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Special Lectures Abstracts.
    Osteoporos Int. 2019;30.
    PubMed    



  154. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2019;30.
    PubMed    


  155. KWAK MK, Lee EJ, Park JW, Park SY, et al
    CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
    Osteoporos Int. 2019;30:1501-1510.
    PubMed     Abstract available


    June 2019
  156. KRISTENSEN PK, Ehrenstein V, Shetty N, Pedersen AB, et al
    Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Osteoporos Int. 2019 Jun 29. pii: 10.1007/s00198-019-05066.
    PubMed     Abstract available


  157. HAGINO H, Narita R, Yokoyama Y, Watanabe M, et al
    A multicenter, randomized, rater-blinded, parallel-group, phase 3 study to compare the efficacy, safety, and immunogenicity of biosimilar RGB-10 and reference once-daily teriparatide in patients with osteoporosis.
    Osteoporos Int. 2019 Jun 26. pii: 10.1007/s00198-019-05038.
    PubMed     Abstract available


  158. JOHANSSON L, Svensson HK, Karlsson J, Olsson LE, et al
    Decreased physical health-related quality of life-a persisting state for older women with clinical vertebral fracture.
    Osteoporos Int. 2019 Jun 21. pii: 10.1007/s00198-019-05044.
    PubMed     Abstract available


  159. MASSERA D, Xu S, Walker MD, Valderrabano RJ, et al
    Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.
    Osteoporos Int. 2019 Jun 21. pii: 10.1007/s00198-019-05043.
    PubMed     Abstract available


  160. GE G, Li J, Wang Q
    Heart failure and fracture risk: a meta-analysis.
    Osteoporos Int. 2019 Jun 19. pii: 10.1007/s00198-019-05042.
    PubMed     Abstract available


  161. LIU C, Wang L, Zhu R, Liu H, et al
    Correction to: Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/beta-catenin signaling pathway in OVX rats.
    Osteoporos Int. 2019 Jun 18. pii: 10.1007/s00198-019-05028.
    PubMed     Abstract available


  162. CARBONE LD, Vasan S, Prentice RL, Harshfield G, et al
    The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.
    Osteoporos Int. 2019 Jun 17. pii: 10.1007/s00198-019-05041.
    PubMed     Abstract available


  163. ASGHAR ZB, Godoy Caballero A, Pathirannehelage S, Williams J, et al
    Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study.
    Osteoporos Int. 2019 Jun 17. pii: 10.1007/s00198-019-05045.
    PubMed     Abstract available


  164. BILEZIKIAN JP, Lin CJF, Brown JP, Wang AT, et al
    Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
    Osteoporos Int. 2019 Jun 14. pii: 10.1007/s00198-019-05020.
    PubMed     Abstract available


  165. DENNISON EM, Cooper C, Kanis JA, Bruyere O, et al
    Fracture risk following intermission of osteoporosis therapy.
    Osteoporos Int. 2019 Jun 7. pii: 10.1007/s00198-019-05002.
    PubMed     Abstract available


  166. PFIMLIN A, Gournay A, Delabriere I, Chantelot C, et al
    Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
    Osteoporos Int. 2019 Jun 5. pii: 10.1007/s00198-019-05036.
    PubMed     Abstract available


  167. VAN DORT MJ, Driessen JHM, Geusens P, Romme EAPM, et al
    Vertebral bone attenuation in Hounsfield Units and prevalent vertebral fractures are associated with the short-term risk of vertebral fractures in current and ex-smokers with and without COPD: a 3-year chest CT follow-up study.
    Osteoporos Int. 2019 Jun 3. pii: 10.1007/s00198-019-04977.
    PubMed     Abstract available


  168. HOIBERG MP, Rubin KH, Holmberg T, Rothmann MJ, et al
    Use of antiosteoporotic medication in the Danish ROSE population-based screening study.
    Osteoporos Int. 2019;30:1223-1233.
    PubMed     Abstract available


  169. CAIROLI E, Eller-Vainicher C, Morlacchi LC, Tarsia P, et al
    Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.
    Osteoporos Int. 2019;30:1255-1263.
    PubMed     Abstract available


    May 2019
  170. NOE S, Jaeger H, Wolf E
    Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis : Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporos
    Osteoporos Int. 2019 May 29. pii: 10.1007/s00198-019-05024.
    PubMed    


  171. BIVER E, Calmy A, Meier C
    Reply to "Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against O
    Osteoporos Int. 2019 May 29. pii: 10.1007/s00198-019-05025.
    PubMed    


  172. SWANSON CM, Blatchford PJ, Orwoll ES, Cauley JA, et al
    Association between objective sleep duration and bone mineral density in older postmenopausal women from the Study of Osteoporotic Fractures (SOF).
    Osteoporos Int. 2019 May 28. pii: 10.1007/s00198-019-05007.
    PubMed     Abstract available


  173. HIDAYAT K, Du X, Shi BM
    Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2019 May 27. pii: 10.1007/s00198-019-04968.
    PubMed     Abstract available


  174. HONG WJ, Chen W, Yeo KJ, Huang PH, et al
    Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan.
    Osteoporos Int. 2019 May 24. pii: 10.1007/s00198-019-04966.
    PubMed     Abstract available


  175. KANTEREWICZ E, Puigoriol E, Rodriguez Cros JR, Peris P, et al
    Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
    Osteoporos Int. 2019 May 23. pii: 10.1007/s00198-019-04962.
    PubMed     Abstract available


  176. HYGUM K, Harslof T, Langdahl B, Starup-Linde J, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk-limitations to current knowledge.
    Osteoporos Int. 2019 May 22. pii: 10.1007/s00198-019-05013.
    PubMed    


  177. ZHOU W, Liu Y, Guo X, Yang H, et al
    Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
    Osteoporos Int. 2019 May 21. pii: 10.1007/s00198-019-05005.
    PubMed     Abstract available



  178. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Committee of National Societies Abstracts.
    Osteoporos Int. 2019 May 17. pii: 10.1007/s00198-019-04981.
    PubMed    


  179. MOTT A, Bradley T, Wright K, Cockayne ES, et al
    Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials.
    Osteoporos Int. 2019 May 10. pii: 10.1007/s00198-019-04949.
    PubMed     Abstract available


  180. HOPMAN WM, Berger C, Joseph L, Morin SN, et al
    Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2019 May 8. pii: 10.1007/s00198-019-05000.
    PubMed     Abstract available


  181. CHANDLER H, Brooks DJ, Hattersley G, Bouxsein ML, et al
    Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
    Osteoporos Int. 2019 May 3. pii: 10.1007/s00198-019-04999.
    PubMed     Abstract available


  182. RUPP T, Butscheidt S, Vettorazzi E, Oheim R, et al
    High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis.
    Osteoporos Int. 2019 May 1. pii: 10.1007/s00198-019-04996.
    PubMed     Abstract available


  183. CHEN WC, Lin EY, Kang YN
    Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2019 May 1. pii: 10.1007/s00198-019-04997.
    PubMed     Abstract available


  184. AHN SH, Kim JH, Cho YY, Suh S, et al
    The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Osteoporos Int. 2019;30:1059-1069.
    PubMed     Abstract available


  185. CHRISTENSEN GL, Halgreen JR, Milenkovski M, Kose A, et al
    Bone turnover markers are differentially affected by pre-analytical handling.
    Osteoporos Int. 2019;30:1137-1141.
    PubMed     Abstract available


  186. LI C, Huang Q, Yang R, Dai Y, et al
    Gut microbiota composition and bone mineral loss-epidemiologic evidence from individuals in Wuhan, China.
    Osteoporos Int. 2019;30:1003-1013.
    PubMed     Abstract available


    April 2019
  187. MINNS LOWE CJ, Toye F, Barker KL
    Men's experiences of having osteoporosis vertebral fractures: a qualitative study using interpretative phenomenological analyses.
    Osteoporos Int. 2019 Apr 30. pii: 10.1007/s00198-019-04973.
    PubMed     Abstract available


  188. JEON CH, Chung NS, Lee HD, Won SH, et al
    Case report: electrical automated massage chair use can induce osteoporotic vertebral compression fracture.
    Osteoporos Int. 2019 Apr 23. pii: 10.1007/s00198-019-04961.
    PubMed     Abstract available


  189. LESLIE WD, Martineau P, Bryanton M, Lix LM, et al
    Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Osteoporos Int. 2019 Apr 23. pii: 10.1007/s00198-019-04975.
    PubMed     Abstract available


  190. BOREK DM, Smith RC, Gruber CN, Gruber BL, et al
    Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study.
    Osteoporos Int. 2019 Apr 22. pii: 10.1007/s00198-019-04963.
    PubMed     Abstract available


  191. ARIAS-MORENO AJ, Hosseini HS, Bevers M, Ito K, et al
    Validation of distal radius failure load predictions by homogenized- and micro-finite element analyses based on second-generation high-resolution peripheral quantitative CT images.
    Osteoporos Int. 2019 Apr 17. pii: 10.1007/s00198-019-04935.
    PubMed     Abstract available


  192. TAIPALE H, Rysa J, Hukkanen J, Koponen M, et al
    Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Osteoporos Int. 2019 Apr 16. pii: 10.1007/s00198-019-04957.
    PubMed     Abstract available


  193. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Correction to: Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2019 Apr 15. pii: 10.1007/s00198-019-04950.
    PubMed     Abstract available


  194. MA M, Huang DG, Liang X, Zhang L, et al
    Integrating transcriptome-wide association study and mRNA expression profiling identifies novel genes associated with bone mineral density.
    Osteoporos Int. 2019 Apr 15. pii: 10.1007/s00198-019-04958.
    PubMed     Abstract available


  195. ZHANG J, Zhang T, Xu X, Cai Q, et al
    Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women.
    Osteoporos Int. 2019 Apr 11. pii: 10.1007/s00198-019-04896.
    PubMed     Abstract available


  196. REGINSTER J-, Bianic F, Campbell R, Martin M, et al
    Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
    Osteoporos Int. 2019 Apr 6. pii: 10.1007/s00198-019-04947.
    PubMed     Abstract available


  197. ROH YH, Lee ES, Ahn J, Kim HS, et al
    Factors affecting willingness to get assessed and treated for osteoporosis.
    Osteoporos Int. 2019 Apr 3. pii: 10.1007/s00198-019-04952.
    PubMed     Abstract available


  198. PASQUALINI L, Ministrini S, Lombardini R, Bagaglia F, et al
    Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass.
    Osteoporos Int. 2019;30:797-806.
    PubMed     Abstract available


  199. KUMAR P, Singh NK, Gargeshwari A, S R, et al
    Changes in middle ear transmission characteristics secondary to altered bone remodelling.
    Osteoporos Int. 2019;30:863-870.
    PubMed     Abstract available


    March 2019
  200. SALARI-MOGHADDAM A, Sadeghi O, Keshteli AH, Larijani B, et al
    Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2019 Mar 29. pii: 10.1007/s00198-019-04948.
    PubMed     Abstract available


  201. BURIAN E, Subburaj K, Mookiah MRK, Rohrmeier A, et al
    Texture analysis of vertebral bone marrow using chemical shift encoding-based water-fat MRI: a feasibility study.
    Osteoporos Int. 2019 Mar 22. pii: 10.1007/s00198-019-04924.
    PubMed     Abstract available


  202. WATTS NB, Hattersley G, Fitzpatrick LA, Wang Y, et al
    Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
    Osteoporos Int. 2019 Mar 21. pii: 10.1007/s00198-019-04890.
    PubMed     Abstract available



  203. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Author Index.
    Osteoporos Int. 2019 Mar 21. pii: 10.1007/s00198-019-04915.
    PubMed    


  204. BULLEN AL, Anderson CAM, Hooker ER, Kado DM, et al
    Correlates of T50 and relationships with bone mineral density in community-living older men: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2019 Mar 18. pii: 10.1007/s00198-019-04925.
    PubMed     Abstract available


  205. BEAUDOIN C, Moore L, Gagne M, Bessette L, et al
    Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression.
    Osteoporos Int. 2019 Mar 14. pii: 10.1007/s00198-019-04919.
    PubMed     Abstract available


  206. PERRIER-CORNET J, Omorou AY, Fauny M, Loeuille D, et al
    Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients.
    Osteoporos Int. 2019 Mar 13. pii: 10.1007/s00198-019-04931.
    PubMed     Abstract available


  207. SALE JEM, Marwah A, Naeem F, Yu W, et al
    Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines.
    Osteoporos Int. 2019 Mar 11. pii: 10.1007/s00198-019-04913.
    PubMed     Abstract available


  208. DEGBOE Y, Eischen M, Apoil PA, Mailhol C, et al
    Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.
    Osteoporos Int. 2019 Mar 7. pii: 10.1007/s00198-019-04918.
    PubMed     Abstract available


  209. EL HAGE C, Hallit S, Akel M, Dagher E, et al
    Osteoporosis awareness and health beliefs among Lebanese women aged 40 years and above.
    Osteoporos Int. 2019 Mar 6. pii: 10.1007/s00198-019-04901.
    PubMed     Abstract available


  210. WU DY, Qiao D, Zhang X, Zhang HQ, et al
    Lipid profiles as potential mediators linking body mass index to osteoporosis among Chinese adults: the Henan Rural Cohort Study.
    Osteoporos Int. 2019 Mar 5. pii: 10.1007/s00198-019-04878.
    PubMed     Abstract available


  211. VALENTINITSCH A, Trebeschi S, Kaesmacher J, Lorenz C, et al
    Opportunistic osteoporosis screening in multi-detector CT images via local classification of textures.
    Osteoporos Int. 2019 Mar 4. pii: 10.1007/s00198-019-04910.
    PubMed     Abstract available


  212. EASTELL R, Mitlak BH, Wang Y, Hu M, et al
    Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE.
    Osteoporos Int. 2019;30:667-673.
    PubMed     Abstract available


  213. KAMIMURA M, Taguchi A, Komatsu M, Koiwai H, et al
    Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese.
    Osteoporos Int. 2019;30:621-628.
    PubMed     Abstract available


    February 2019
  214. SPECHBACH H, Fabreguet I, Saule E, Hars M, et al
    Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients.
    Osteoporos Int. 2019 Feb 28. pii: 10.1007/s00198-019-04900.
    PubMed     Abstract available


  215. HARVEY NC, Kanis JA, Liu E, Johansson H, et al
    Appendicular lean mass and fracture risk assessment: implications for FRAX(R) and sarcopenia.
    Osteoporos Int. 2019 Feb 27. pii: 10.1007/s00198-019-04904.
    PubMed    


  216. ADAMI G, Saag KG
    Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04906.
    PubMed     Abstract available


  217. LORENTZON M, Nilsson AG, Johansson H, Kanis JA, et al
    Extensive undertreatment of osteoporosis in older Swedish women.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04872.
    PubMed     Abstract available


  218. BARTOSCH P, McGuigan FE, Akesson KE
    Correction to: Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2019 Feb 25. pii: 10.1007/s00198-019-04876.
    PubMed     Abstract available


  219. LI TC, Li CI, Liu CS, Lin WY, et al
    Visit-to-visit blood pressure variability and hip fracture risk in older persons.
    Osteoporos Int. 2019 Feb 21. pii: 10.1007/s00198-019-04899.
    PubMed     Abstract available



  220. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018-Posters Abstracts.
    Osteoporos Int. 2019 Feb 20. pii: 10.1007/s00198-018-04815.
    PubMed    


  221. WANG J, Yan D, Zhao A, Hou X, et al
    Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
    Osteoporos Int. 2019 Feb 18. pii: 10.1007/s00198-019-04892.
    PubMed     Abstract available


  222. LOPEZ PICAZO M, Humbert L, Di Gregorio S, Gonzalez Ballester MA, et al
    Discrimination of osteoporosis-related vertebral fractures by DXA-derived 3D measurements: a retrospective case-control study.
    Osteoporos Int. 2019 Feb 15. pii: 10.1007/s00198-019-04894.
    PubMed     Abstract available


  223. ACOSTA-MERIDA A, Ojeda-Bruno S
    Multiple vertebral fractures as the first manifestation of systemic mastocytosis.
    Osteoporos Int. 2019 Feb 15. pii: 10.1007/s00198-019-04897.
    PubMed     Abstract available


  224. ZHOU Q, Xie F, Zhou B, Wang J, et al
    Differentially expressed proteins identified by TMT proteomics analysis in bone marrow microenvironment of osteoporotic patients.
    Osteoporos Int. 2019 Feb 9. pii: 10.1007/s00198-019-04884.
    PubMed     Abstract available


  225. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Risk of osteoporosis and fracture in victims with burn injury.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-018-04818.
    PubMed     Abstract available


  226. DE BRUIN IJA, Klop C, Wyers CE, Overbeek JA, et al
    All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-019-04851.
    PubMed     Abstract available



  227. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Oral Communications Abstracts.
    Osteoporos Int. 2019 Feb 8. pii: 10.1007/s00198-018-04814.
    PubMed    


  228. SU S, He N, Men P, Song C, et al
    The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2019 Feb 7. pii: 10.1007/s00198-019-04853.
    PubMed     Abstract available


  229. CHEN WJ, Livneh H, Hsieh MH, Yeh CC, et al
    Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study.
    Osteoporos Int. 2019 Feb 5. pii: 10.1007/s00198-018-4789.
    PubMed     Abstract available


    January 2019
  230. SOLIMEO SL, Nguyen VT, Edmonds SW, Lou Y, et al
    Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-019-04854.
    PubMed     Abstract available


  231. HILIGSMANN M, Reginster JY
    Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-018-04821.
    PubMed     Abstract available



  232. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Committee of National Societies (CNS) Roundtable Abstracts.
    Osteoporos Int. 2019 Jan 30. pii: 10.1007/s00198-018-04812.
    PubMed    



  233. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia - 2018 - IOF-OA-ANZBMS Joint Session Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04811.
    PubMed    



  234. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Sponsored Symposia Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04813.
    PubMed    



  235. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Opening ceremony Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04808.
    PubMed    



  236. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Plenary Lecture Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04807.
    PubMed    



  237. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - Meet-the-Expert Sessions Abstracts.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-018-04809.
    PubMed    


  238. BEZERRA DE CARVALHO KS, Vasco RFV, Custodio MR, Jorgetti V, et al
    Chronic kidney disease is associated with low BMD at the hip but not at the spine.
    Osteoporos Int. 2019 Jan 28. pii: 10.1007/s00198-019-04864.
    PubMed     Abstract available


  239. LYU H, Yoshida K, Tedeschi SK, Zhao S, et al
    Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.
    Osteoporos Int. 2019 Jan 24. pii: 10.1007/s00198-019-04847.
    PubMed     Abstract available


  240. BANEFELT J, Akesson KE, Spangeus A, Ljunggren O, et al
    Risk of imminent fracture following a previous fracture in a Swedish database study.
    Osteoporos Int. 2019 Jan 24. pii: 10.1007/s00198-019-04852.
    PubMed     Abstract available


  241. HARDCASTLE SA, Yahya F, Bhalla AK
    Pregnancy-associated osteoporosis: a UK case series and literature review.
    Osteoporos Int. 2019 Jan 23. pii: 10.1007/s00198-019-04842.
    PubMed     Abstract available


  242. CHEHADE LK, Curragh D, Selva D
    Bisphosphonate-induced orbital inflammation: more common than once thought?
    Osteoporos Int. 2019 Jan 23. pii: 10.1007/s00198-019-04850.
    PubMed     Abstract available


  243. WANG YXJ, Che-Nordin N, Deng M, Leung JCS, et al
    Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS (Hong Kong) study results.
    Osteoporos Int. 2019 Jan 22. pii: 10.1007/s00198-019-04856.
    PubMed     Abstract available



  244. IOF Regional 7th Asia-Pacific Osteoporosis Conference Sydney, Australia 2018 - IOF-APOA Joint Session Abstracts.
    Osteoporos Int. 2019 Jan 21. pii: 10.1007/s00198-018-04810.
    PubMed    


  245. NORIEGA DC, Rodriotaguez-Monsalve F, Ramajo R, Sanchez-Lite I, et al
    Correction to: Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2019 Jan 18. pii: 10.1007/s00198-018-04825.
    PubMed     Abstract available


  246. KOLDKJAER SOLLING AS, Harslof T, Langdahl B
    Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
    Osteoporos Int. 2019 Jan 17. pii: 10.1007/s00198-018-04833.
    PubMed     Abstract available


  247. TAMAKI J, Fujimori K, Ikehara S, Kamiya K, et al
    Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.
    Osteoporos Int. 2019 Jan 16. pii: 10.1007/s00198-019-04844.
    PubMed     Abstract available


  248. ZHU RS, Kan SL, Ning GZ, Chen LX, et al
    Which is the best treatment of osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis.
    Osteoporos Int. 2019 Jan 12. pii: 10.1007/s00198-018-4804.
    PubMed     Abstract available


  249. ADAMS AL, Li BH, Bhandari S, Kamat S, et al
    Chronic hyponatremia and association with osteoporosis among a large racially/ethnically diverse population.
    Osteoporos Int. 2019 Jan 11. pii: 10.1007/s00198-018-04832.
    PubMed     Abstract available


  250. TREISTER-GOLTZMAN Y, Peleg R
    Primary lactase deficiency and bone mineral density in postmenopausal women.
    Osteoporos Int. 2019 Jan 11. pii: 10.1007/s00198-018-4799.
    PubMed    


  251. NAYAK S, Greenspan SL
    A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-4791.
    PubMed     Abstract available


  252. RUDMAN HA, Birrell F, Pearce MS, Tuck SP, et al
    Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.
    Osteoporos Int. 2019 Jan 8. pii: 10.1007/s00198-018-04817.
    PubMed     Abstract available


  253. NAYLOR KE, McCloskey EV, Jacques RM, Peel NFA, et al
    Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04823.
    PubMed     Abstract available


  254. LAMY O, Fernandez-Fernandez E, Monjo-Henry I, Stoll D, et al
    Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
    Osteoporos Int. 2019 Jan 6. pii: 10.1007/s00198-018-04820.
    PubMed     Abstract available


  255. WATSON SL, Weeks BK, Weis LJ, Harding AT, et al
    High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial.
    Osteoporos Int. 2019 Jan 5. pii: 10.1007/s00198-018-04829.
    PubMed     Abstract available


  256. MORIWAKI K, Fukuda H
    Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.
    Osteoporos Int. 2019 Jan 4. pii: 10.1007/s00198-018-4798.
    PubMed     Abstract available


  257. FUJITA K, Kaburagi H, Nimura A, Miyamoto T, et al
    Lower grip strength and dynamic body balance in women with distal radial fractures.
    Osteoporos Int. 2019 Jan 4. pii: 10.1007/s00198-018-04816.
    PubMed     Abstract available


  258. BLIUC D, Tran T, van Geel T, Adachi JD, et al
    Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study.
    Osteoporos Int. 2019 Jan 3. pii: 10.1007/s00198-018-4806.
    PubMed     Abstract available


  259. WANG T, Yang L, Jiang J, Liu Y, et al
    Pulsed electromagnetic fields: promising treatment for osteoporosis.
    Osteoporos Int. 2019 Jan 2. pii: 10.1007/s00198-018-04822.
    PubMed     Abstract available


  260. BIVER E, Calmy A, Aubry-Rozier B, Birkhauser M, et al
    Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
    Osteoporos Int. 2019 Jan 2. pii: 10.1007/s00198-018-4794.
    PubMed     Abstract available


    December 2018
  261. ALTINBAS A
    Osteoporosis risk of the subjects with isolated lactase enzyme deficiency.
    Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4736.
    PubMed    


  262. GEUSENS P, van den Bergh J
    Comments on Kanis et al.: Characteristics of recurrent fractures.
    Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4735.
    PubMed    


  263. YANG S, Leslie WD, Morin SN, Lix LM, et al
    Administrative healthcare data applied to fracture risk assessment.
    Osteoporos Int. 2018 Dec 15. pii: 10.1007/s00198-018-4780.
    PubMed     Abstract available


  264. ELHAKEEM A, Hartley A, Luo Y, Goertzen AL, et al
    Lean mass and lower limb muscle function in relation to hip strength, geometry and fracture risk indices in community-dwelling older women.
    Osteoporos Int. 2018 Dec 14. pii: 10.1007/s00198-018-4795.
    PubMed     Abstract available


  265. LOU S, Lv H, Yin P, Li Z, et al
    Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2018 Dec 11. pii: 10.1007/s00198-018-4790.
    PubMed     Abstract available


  266. IKI M, Tamaki J, Sato Y, Winzenrieth R, et al
    Correction to: Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study.
    Osteoporos Int. 2018 Dec 11. pii: 10.1007/s00198-018-4779.
    PubMed     Abstract available


  267. LEE DR, Lee J
    Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study.
    Osteoporos Int. 2018 Dec 8. pii: 10.1007/s00198-018-4778.
    PubMed     Abstract available


  268. CHE H, Breuil V, Cortet B, Paccou J, et al
    Vertebral fractures cascade: potential causes and risk factors.
    Osteoporos Int. 2018 Dec 5. pii: 10.1007/s00198-018-4793.
    PubMed     Abstract available


  269. ZHU W, Xu C, Zhang JG, He H, et al
    Gene-based GWAS analysis for consecutive studies of GEFOS.
    Osteoporos Int. 2018;29:2645-2658.
    PubMed     Abstract available


  270. KENDLER DL, Body JJ, Brandi ML, Broady R, et al
    Bone management in hematologic stem cell transplant recipients.
    Osteoporos Int. 2018;29:2597-2610.
    PubMed     Abstract available


    November 2018
  271. NORIEGA DC
    Long-term safety and clinical performance of kyphoplasty and SpineJack(R) procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4773.
    PubMed     Abstract available


  272. WU Q
    Depression and antidepressant medications: both are linked to increased fracture risk.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4785.
    PubMed    


  273. PIENKOWSKI D, Wood CL, Malluche HH
    Young's modulus and hardness of human trabecular bone with bisphosphonate treatment durations up to 20 years.
    Osteoporos Int. 2018 Nov 28. pii: 10.1007/s00198-018-4760.
    PubMed     Abstract available


  274. KURODA T, Uenishi K, Ohta H, Shiraki M, et al
    Multiple vitamin deficiencies additively increase the risk of incident fractures in Japanese postmenopausal women.
    Osteoporos Int. 2018 Nov 27. pii: 10.1007/s00198-018-4784.
    PubMed     Abstract available


  275. HOLMBERG T, Moller S, Rothmann MJ, Gram J, et al
    Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study.
    Osteoporos Int. 2018 Nov 21. pii: 10.1007/s00198-018-4768.
    PubMed     Abstract available


  276. BALASUBRAMANIAN A, Zhang J, Chen L, Wenkert D, et al
    Risk of subsequent fracture after prior fracture among older women.
    Osteoporos Int. 2018 Nov 19. pii: 10.1007/s00198-018-4732.
    PubMed     Abstract available


  277. YEAM CT, Chia S, Tan HCC, Kwan YH, et al
    A systematic review of factors affecting medication adherence among patients with osteoporosis.
    Osteoporos Int. 2018 Nov 12. pii: 10.1007/s00198-018-4759.
    PubMed     Abstract available


  278. HAMOOD R, Hamood H, Merhasin I, Keinan-Boker L, et al
    Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.
    Osteoporos Int. 2018 Nov 9. pii: 10.1007/s00198-018-4758.
    PubMed     Abstract available



  279. Osteoporosis Conference 2018 Birmingham, UK 2 - 4 December 2018 Abstracts.
    Osteoporos Int. 2018 Nov 7. pii: 10.1007/s00198-018-4738.
    PubMed    


    October 2018
  280. HILIGSMANN M, Reginster JY, Tosteson ANA, Bukata SV, et al
    Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
    Osteoporos Int. 2018 Oct 31. pii: 10.1007/s00198-018-4744.
    PubMed     Abstract available


  281. LIU B, Wu Q, Zhang S, Del Rosario A, et al
    Lithium use and risk of fracture: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Oct 29. pii: 10.1007/s00198-018-4745.
    PubMed     Abstract available


  282. YU WB, Jiang XB, Liang D, Xu WX, et al
    Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2018 Oct 28. pii: 10.1007/s00198-018-4754.
    PubMed     Abstract available


  283. TAKACS I, Jokai E, Kovats DE, Aradi I, et al
    The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.
    Osteoporos Int. 2018 Oct 24. pii: 10.1007/s00198-018-4741.
    PubMed     Abstract available


  284. HAIDER IT, Lobos SM, Simonian N, Schnitzer TJ, et al
    Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.
    Osteoporos Int. 2018 Oct 17. pii: 10.1007/s00198-018-4733.
    PubMed     Abstract available


  285. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
    Osteoporos Int. 2018 Oct 15. pii: 10.1007/s00198-018-4704.
    PubMed     Abstract available


  286. TORRES L, Klingberg E, Nurkkala M, Carlsten H, et al
    Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4721.
    PubMed     Abstract available


  287. MERLE B, Dupraz C, Haesebaert J, Barraud L, et al
    Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4720.
    PubMed     Abstract available


  288. ALLAIRE BT, Lu D, Johannesdottir F, Kopperdahl D, et al
    Prediction of incident vertebral fracture using CT-based finite element analysis.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4716.
    PubMed     Abstract available


  289. BIVER E, Pepe J, de Sire A, Chevalley T, et al
    Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women.
    Osteoporos Int. 2018 Oct 10. pii: 10.1007/s00198-018-4725.
    PubMed     Abstract available


  290. STOLZENBERG N, Felsenberg D, Belavy DL
    Postural control is associated with muscle power in post-menopausal women with low bone mass.
    Osteoporos Int. 2018;29:2283-2288.
    PubMed     Abstract available


  291. IRELAND A, Crozier SR, Heazell AEP, Ward KA, et al
    Breech presentation is associated with lower bone mass and area: findings from the Southampton Women's Survey.
    Osteoporos Int. 2018;29:2275-2281.
    PubMed     Abstract available


    September 2018
  292. KENDLER DL, Chines A, Brandi ML, Papapoulos S, et al
    The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies.
    Osteoporos Int. 2018 Sep 22. pii: 10.1007/s00198-018-4687.
    PubMed     Abstract available


  293. MCALISTER FA, Ye C, Beaupre LA, Rowe BH, et al
    Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    Osteoporos Int. 2018 Sep 19. pii: 10.1007/s00198-018-4702.
    PubMed     Abstract available


  294. KIM J, Kim SW, Lee SY, Kim TH, et al
    Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis.
    Osteoporos Int. 2018 Sep 17. pii: 10.1007/s00198-018-4695.
    PubMed     Abstract available


  295. AKHTAR ALI S, Ng C, Votava-Smith JK, Randolph LM, et al
    Bisphosphonate therapy in an infant with generalized arterial calcification with an ABCC6 mutation.
    Osteoporos Int. 2018 Sep 11. pii: 10.1007/s00198-018-4639.
    PubMed     Abstract available


  296. NGUYEN LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, et al
    Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Osteoporos Int. 2018 Sep 8. pii: 10.1007/s00198-018-4700.
    PubMed     Abstract available


  297. AL-SARI UA, Tobias JH, Clark EM
    Impact of mild and moderate/severe vertebral fractures on physical activity: a prospective study of older women in the UK.
    Osteoporos Int. 2018 Sep 7. pii: 10.1007/s00198-018-4692.
    PubMed     Abstract available


  298. MIYAOKA D, Imanishi Y, Ohara M, Hayashi N, et al
    Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Osteoporos Int. 2018 Sep 5. pii: 10.1007/s00198-018-4688.
    PubMed     Abstract available


  299. DI PAOLA M, Gatti D, Viapiana O, Cianferotti L, et al
    Radiofrequency echographic multispectrometry compared with dual X-ray absorptiometry for osteoporosis diagnosis on lumbar spine and femoral neck.
    Osteoporos Int. 2018 Sep 4. pii: 10.1007/s00198-018-4686.
    PubMed     Abstract available


  300. LIU Y, Dimango E, Bucovsky M, Agarwal S, et al
    Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids.
    Osteoporos Int. 2018;29:2121-2127.
    PubMed     Abstract available


    August 2018
  301. BLATY T, Krueger D, Illgen R, Squire M, et al
    DXA evaluation of femoral bone mineral density and cortical width in patients with prior total knee arthroplasty.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4682.
    PubMed     Abstract available


  302. SOKAL A, Elefant E, Leturcq T, Beghin D, et al
    Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.
    Osteoporos Int. 2018 Aug 31. pii: 10.1007/s00198-018-4672.
    PubMed     Abstract available


  303. HALASI A, Kincse G, Varga J, Keri J, et al
    Tight control: a new therapeutic strategy in the management of osteoporotic patients.
    Osteoporos Int. 2018 Aug 30. pii: 10.1007/s00198-018-4674.
    PubMed     Abstract available


  304. LIU C, Wang L, Zhu R, Liu H, et al
    Rehmanniae Radix Preparata suppresses bone loss and increases bone strength through interfering with canonical Wnt/beta-catenin signaling pathway in OVX rats.
    Osteoporos Int. 2018 Aug 27. pii: 10.1007/s00198-018-4670.
    PubMed     Abstract available


  305. SHIMIZU Y, Sawada N, Nakamura K, Watanabe Y, et al
    Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.
    Osteoporos Int. 2018 Aug 24. pii: 10.1007/s00198-018-4665.
    PubMed     Abstract available


  306. BARZILAY JI, Buzkova P, Cauley JA, Robbins JA, et al
    The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults.
    Osteoporos Int. 2018 Aug 21. pii: 10.1007/s00198-018-4611.
    PubMed     Abstract available


  307. HAUGER AV, Bergland A, Holvik K, Stahle A, et al
    Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromso Study.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4653.
    PubMed     Abstract available


  308. MAZZUCCHELLI R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, et al
    Short-term association between outdoor air pollution and osteoporotic hip fracture.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4605.
    PubMed     Abstract available


  309. XU Y, Wu Q
    Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4648.
    PubMed     Abstract available


  310. GIANGREGORIO LM, Gibbs JC, Templeton JA, Adachi JD, et al
    Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4652.
    PubMed     Abstract available


  311. ZHANG YS, Weng WY, Xie BC, Meng Y, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2018 Aug 6. pii: 10.1007/s00198-018-4649.
    PubMed     Abstract available


  312. GAMBOA A, Duaso E, Marimon P, Sandiumenge M, et al
    Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Osteoporos Int. 2018 Aug 3. pii: 10.1007/s00198-018-4622.
    PubMed     Abstract available


  313. JIANG N, Xia W
    Assessment of bone quality in patients with diabetes mellitus.
    Osteoporos Int. 2018;29:1721-1736.
    PubMed     Abstract available


    July 2018
  314. FERRARI SL, Abrahamsen B, Napoli N, Akesson K, et al
    Diagnosis and management of bone fragility in diabetes: an emerging challenge.
    Osteoporos Int. 2018 Jul 31. pii: 10.1007/s00198-018-4650.
    PubMed     Abstract available


  315. MUNHOZ DA ROCHA LEMOS COSTA T, Costa FM, Hoffman Jonasson T, Aguiar Moreira C, et al
    Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4643.
    PubMed     Abstract available


  316. HIDAYAT K, Du X, Shi BM
    Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jul 24. pii: 10.1007/s00198-018-4600.
    PubMed     Abstract available


  317. LIM SJ, Yeo I, Yoon PW, Yoo JJ, et al
    Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Osteoporos Int. 2018 Jul 23. pii: 10.1007/s00198-018-4640.
    PubMed     Abstract available


  318. KYVERNITAKIS I, Kostev K, Hadji P
    The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.
    Osteoporos Int. 2018 Jul 21. pii: 10.1007/s00198-018-4642.
    PubMed     Abstract available


  319. SONG LJ, Wang LL, Ning L, Fan SW, et al
    A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4641.
    PubMed     Abstract available


  320. KANAZAWA I, Notsu M, Miyake H, Tanaka K, et al
    Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4638.
    PubMed     Abstract available


  321. NORDKLINT AK, Almdal TP, Vestergaard P, Lundby-Christensen L, et al
    The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
    Osteoporos Int. 2018 Jul 19. pii: 10.1007/s00198-018-4637.
    PubMed     Abstract available


  322. LIU J, Guo H, Rai P, Pinto L, et al
    Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Osteoporos Int. 2018 Jul 18. pii: 10.1007/s00198-018-4630.
    PubMed     Abstract available


  323. CHOI CK, Kweon S-, Lee Y-, Nam H-, et al
    Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4386.
    PubMed     Abstract available


  324. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4615.
    PubMed    


  325. TREISTER-GOLTZMAN Y, Friger M, Peleg R
    Does primary lactase deficiency reduce bone mineral density in postmenopausal women? A systematic review and meta-analysis.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4635.
    PubMed     Abstract available


  326. CHRISTIANSEN BA, Harrison SL, Fink HA, Lane NE, et al
    Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4606.
    PubMed     Abstract available


  327. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4536.
    PubMed     Abstract available


  328. MO XB, Zhang YH, Lei SF
    Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density.
    Osteoporos Int. 2018 Jul 7. pii: 10.1007/s00198-018-4573.
    PubMed     Abstract available


  329. AMORIM T, Duraes C, Machado JC, Metsios GS, et al
    Genetic variation in Wnt/beta-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4610.
    PubMed     Abstract available


  330. WU QY, Yuan FL, Wang B, Li X, et al
    Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4614.
    PubMed    


  331. WINZENRIETH R, Humbert L, Di Gregorio S, Bonel E, et al
    Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling.
    Osteoporos Int. 2018 Jul 4. pii: 10.1007/s00198-018-4624.
    PubMed     Abstract available


  332. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    Correction to: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Jul 3. pii: 10.1007/s00198-018-4497.
    PubMed     Abstract available


  333. HO-PHAM LT, Chau PMN, Do AT, Nguyen HC, et al
    Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4579.
    PubMed     Abstract available


  334. SHUDO A, Kishimoto H, Takaoka K, Noguchi K, et al
    Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4621.
    PubMed     Abstract available


    June 2018
  335. LIU LC, Lu MC, Wang SY, Livneh H, et al
    Association of use of rehabilitation services with development of osteoporosis among patients with rheumatoid arthritis: a nationwide population-based cohort study.
    Osteoporos Int. 2018 Jun 27. pii: 10.1007/s00198-018-4569.
    PubMed     Abstract available


  336. SMITH BJ, Leyva MJ, Stephens LD, Aston CE, et al
    Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma.
    Osteoporos Int. 2018 Jun 25. pii: 10.1007/s00198-018-4594.
    PubMed     Abstract available


  337. GIORDANO S, Proietti A, Bisaccia T, Caso P, et al
    Hypovitaminosis D: comparison between patients with hip fracture and patients with vertebral fractures.
    Osteoporos Int. 2018 Jun 23. pii: 10.1007/s00198-018-4582.
    PubMed     Abstract available


  338. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
    Osteoporos Int. 2018 Jun 21. pii: 10.1007/s00198-018-4596.
    PubMed     Abstract available


  339. SZAFORS P, Che H, Barnetche T, Morel J, et al
    Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Osteoporos Int. 2018 Jun 16. pii: 10.1007/s00198-018-4586.
    PubMed     Abstract available


  340. CHEN H, Lips P, Vervloet MG, van Schoor NM, et al
    Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
    Osteoporos Int. 2018 Jun 15. pii: 10.1007/s00198-018-4592.
    PubMed     Abstract available


  341. BARTOSCH P, McGuigan FE, Akesson KE
    Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4593.
    PubMed     Abstract available


  342. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
    Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
    Osteoporos Int. 2018 Jun 8. pii: 10.1007/s00198-018-4505.
    PubMed     Abstract available


  343. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4504.
    PubMed     Abstract available


  344. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Abstract available


  345. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Abstract available


  346. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Abstract available


  347. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Abstract available


  348. CARLSON BC, Robinson WA, Wanderman NR, Nassr AN, et al
    The American Orthopaedic Association's Own the Bone(R) database: a national quality improvement project for the treatment of bone health in fragility fracture patients.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4585.
    PubMed     Abstract available


  349. JAIN RK, Vokes T
    Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4584.
    PubMed     Abstract available


    May 2018
  350. CAI X, Yi X, Zhang Y, Zhang D, et al
    Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4575.
    PubMed     Abstract available


  351. LENCHIK L, Register TC, Russell GB, Xu J, et al
    Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4578.
    PubMed     Abstract available


  352. HOFF M, Skurtveit S, Meyer HE, Langhammer A, et al
    Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4560.
    PubMed     Abstract available


  353. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Abstract available


  354. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Abstract available


  355. RIZZOLI R, Biver E, Bonjour JP, Coxam V, et al
    Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4534.
    PubMed     Abstract available


  356. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation.
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4379.
    PubMed     Abstract available


  357. BIVER E, Durosier-Izart C, Merminod F, Chevalley T, et al
    Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.
    Osteoporos Int. 2018 May 3. pii: 10.1007/s00198-018-4535.
    PubMed     Abstract available


  358. XIAO X, Roohani D, Wu Q
    Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Osteoporos Int. 2018 May 1. pii: 10.1007/s00198-018-4546.
    PubMed     Abstract available


  359. LOCQUET M, Beaudart C, Bruyere O, Kanis JA, et al
    Bone health assessment in older people with or without muscle health impairment.
    Osteoporos Int. 2018;29:1057-1067.
    PubMed     Abstract available


  360. ZIEBART C, McArthur C, Lee L, Papaioannou A, et al
    "Left to my own devices, I don't know": using theory and patient-reported barriers to move from physical activity recommendations to practice.
    Osteoporos Int. 2018;29:1081-1091.
    PubMed     Abstract available


    April 2018
  361. THONGPRAYOON C, Acharya P, Acharya C, Chenbhanich J, et al
    Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Osteoporos Int. 2018 Apr 30. pii: 10.1007/s00198-018-4533.
    PubMed     Abstract available


  362. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Abstract available


  363. AHMADI N, Mao SS, Hajsadeghi F, Arnold B, et al
    The relation of low levels of bone mineral density with coronary artery calcium and mortality.
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4524.
    PubMed     Abstract available


  364. DELL R, Greene D
    A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
    PubMed     Abstract available


  365. SHI M, Chen L, Xin Z, Wang Y, et al
    Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
    Osteoporos Int. 2018 Apr 13. pii: 10.1007/s00198-018-4488.
    PubMed     Abstract available


  366. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Abstract available


  367. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Abstract available


  368. KOSTEV K
    Association between gout and osteoporosis risk in the United Kingdom.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4477.
    PubMed    


  369. KOK VC
    Gout as a risk factor for osteoporosis: response to comments by Kostev.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4478.
    PubMed    


  370. LIU Y, Levack AE, Marty E, Or O, et al
    Anabolic agents: what is beyond osteoporosis?
    Osteoporos Int. 2018 Apr 7. pii: 10.1007/s00198-018-4507.
    PubMed     Abstract available


  371. KEMMLER W, Shojaa M, Kohl M, von Stengel S, et al
    Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions.
    Osteoporos Int. 2018 Apr 5. pii: 10.1007/s00198-018-4482.
    PubMed     Abstract available


  372. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4476.
    PubMed     Abstract available



  373. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2018;29.
    PubMed    



  374. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Author Index.
    Osteoporos Int. 2018;29.
    PubMed    



  375. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  376. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Plenary Lectures Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  377. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Educational Lecture Abstract.
    Osteoporos Int. 2018;29.
    PubMed    



  378. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  379. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Satellite Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  380. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO-WHO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  381. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Oral Communication Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  382. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  383. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  384. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Meet-the-Expert Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  385. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    



  386. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Committee of National Societies Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    


  387. ROSEVEARE D
    World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Poster Abstracts.
    Osteoporos Int. 2018;29.
    PubMed    


  388. T YIN M, RoyChoudhury A, Nishiyama K, Lang T, et al
    Bone density and microarchitecture in hepatitis C and HIV-coinfected postmenopausal minority women.
    Osteoporos Int. 2018;29:871-879.
    PubMed     Abstract available


  389. SHEN CL, Yang S, Tomison MD, Romero AW, et al
    Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial.
    Osteoporos Int. 2018;29:881-891.
    PubMed     Abstract available


    March 2018
  390. BUTSCHEIDT S, Delsmann A, Rolvien T, Barvencik F, et al
    Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
    Osteoporos Int. 2018 Mar 29. pii: 10.1007/s00198-018-4499.
    PubMed     Abstract available


  391. WANG D, Ruan W, Peng Y, Li W, et al
    Sleep duration and the risk of osteoporosis among middle-aged and elderly adults: a dose-response meta-analysis.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4487.
    PubMed     Abstract available


  392. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Abstract available


  393. KUMAGAI K, Harigane K, Kusayama Y, Tezuka T, et al
    Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4494.
    PubMed     Abstract available


  394. EBINA K, Hirao M, Hashimoto J, Matsuoka H, et al
    Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naive rheumatoid arthritis.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4492.
    PubMed     Abstract available


  395. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Abstract available


  396. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Abstract available


  397. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Abstract available


  398. NAYLOR KE, Bradburn M, Paggiosi MA, Gossiel F, et al
    Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-018-4460.
    PubMed     Abstract available


  399. WU CH, Chen CH, Chen PH, Yang JJ, et al
    Identifying characteristics of an effective fracture liaison service: systematic literature review.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-017-4370.
    PubMed     Abstract available


  400. LEVIN VA, Jiang X, Kagan R
    Estrogen therapy for osteoporosis in the modern era.
    Osteoporos Int. 2018 Mar 8. pii: 10.1007/s00198-018-4414.
    PubMed     Abstract available


  401. LUO Y
    Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4461.
    PubMed     Abstract available


  402. SEGAUD N, Legroux I, Hazzan M, Noel C, et al
    Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4383.
    PubMed     Abstract available


  403. LESLIE WD, Shevroja E, Johansson H, McCloskey EV, et al
    Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.
    Osteoporos Int. 2018;29:751-758.
    PubMed     Abstract available


  404. SHAH VN, Sippl R, Joshee P, Pyle L, et al
    Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance.
    Osteoporos Int. 2018;29:733-739.
    PubMed     Abstract available


  405. WANG Z, Wang D, Yang D, Zhen W, et al
    The effect of icariin on bone metabolism and its potential clinical application.
    Osteoporos Int. 2018;29:535-544.
    PubMed     Abstract available


    February 2018
  406. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Correction to: Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4449.
    PubMed     Abstract available


  407. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Abstract available


  408. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Abstract available


  409. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Abstract available


  410. MARCUS R
    Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-017-4177.
    PubMed    


  411. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Abstract available


  412. KARJALAINEN JP, Riekkinen O, Kroger H
    Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4408.
    PubMed     Abstract available


  413. GALLI S
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation: response to comments by Marcus.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4430.
    PubMed    


  414. WU CH, Kao IJ, Hung WC, Lin SC, et al
    Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
    PubMed     Abstract available


  415. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Abstract available


  416. ROGERS TS, Harrison S, Judd S, Orwoll ES, et al
    Dietary patterns and longitudinal change in hip bone mineral density among older men.
    Osteoporos Int. 2018 Feb 15. pii: 10.1007/s00198-018-4388.
    PubMed     Abstract available


  417. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Abstract available


  418. ZHOU C, Fang L, Chen Y, Zhong J, et al
    Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Feb 12. pii: 10.1007/s00198-018-4413.
    PubMed     Abstract available


  419. GREENSPAN SL, Singer A, Vujevich K, Marchand B, et al
    Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Osteoporos Int. 2018 Feb 10. pii: 10.1007/s00198-017-4371.
    PubMed     Abstract available


  420. MORI Y, Kasai H, Ose A, Serada M, et al
    Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Osteoporos Int. 2018 Feb 8. pii: 10.1007/s00198-018-4376.
    PubMed     Abstract available


  421. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-018-4415.
    PubMed     Abstract available



  422. Erratum to: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-017-4135.
    PubMed     Abstract available


  423. HAMDY RC, Seier E, Whalen K, Clark WA, et al
    FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4368.
    PubMed     Abstract available


  424. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Abstract available


  425. BILEZIKIAN JP, Hattersley G, Fitzpatrick LA, Harris AG, et al
    Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Osteoporos Int. 2018;29:323-328.
    PubMed     Abstract available


  426. OSIMA M, Borgen TT, Lukic M, Grimnes G, et al
    Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromso Study.
    Osteoporos Int. 2018;29:421-431.
    PubMed     Abstract available


    January 2018
  427. KOK VC, Horng JT, Wang MN, Chen ZY, et al
    Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
    Osteoporos Int. 2018 Jan 30. pii: 10.1007/s00198-018-4375.
    PubMed     Abstract available


  428. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Abstract available


  429. NEWMAN M, Newman R, Hughes T, Vadher K, et al
    Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4358.
    PubMed     Abstract available


  430. MOOKIAH MRK, Rohrmeier A, Dieckmeyer M, Mei K, et al
    Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis.
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4342.
    PubMed     Abstract available


  431. VARAHRA A, Rodrigues IB, MacDermid JC, Bryant D, et al
    Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Jan 6. pii: 10.1007/s00198-017-4339.
    PubMed     Abstract available


  432. GIFRE L, Humbert L, Muxi A, Del Rio L, et al
    Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.
    Osteoporos Int. 2018;29:201-209.
    PubMed     Abstract available


  433. BELAYA ZE, Grebennikova TA, Melnichenko GA, Nikitin AG, et al
    Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans.
    Osteoporos Int. 2018;29:211-221.
    PubMed     Abstract available


  434. LESLIE WD, Morin SN, Majumdar SR, Lix LM, et al
    Effects of obesity and diabetes on rate of bone density loss.
    Osteoporos Int. 2018;29:61-67.
    PubMed     Abstract available


    December 2017
  435. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Abstract available


  436. MICHAEL LEWIECKI E, Wright NC, Curtis JR, Siris E, et al
    Hip fracture trends in the United States, 2002 to 2015.
    Osteoporos Int. 2017 Dec 27. pii: 10.1007/s00198-017-4345.
    PubMed     Abstract available


  437. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2017 Dec 23. pii: 10.1007/s00198-017-4351.
    PubMed     Abstract available


  438. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Abstract available


  439. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Abstract available


  440. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Abstract available


  441. HTET TD, Eisman JA, Elder GJ, Center JR, et al
    Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Osteoporos Int. 2017 Dec 15. pii: 10.1007/s00198-017-4330.
    PubMed     Abstract available


  442. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Abstract available


  443. RUBIN KH, Rothmann MJ, Holmberg T, Hoiberg M, et al
    Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4326.
    PubMed     Abstract available


  444. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Abstract available


  445. BOSKEY AL, Spevak L, Ma Y, Wang H, et al
    Insights into the bisphosphonate holiday: a preliminary FTIRI study.
    Osteoporos Int. 2017 Dec 5. pii: 10.1007/s00198-017-4324.
    PubMed     Abstract available


  446. MARTIN-MERINO E, Petersen I, Hawley S, Alvarez-Gutierrez A, et al
    Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4308.
    PubMed     Abstract available


  447. AREECKAL AS, Jayasheelan N, Kamath J, Zawadynski S, et al
    Early diagnosis of osteoporosis using radiogrammetry and texture analysis from hand and wrist radiographs in Indian population.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4328.
    PubMed     Abstract available


  448. JONSSON E, Hansson-Hedblom A, Ljunggren O, Akesson K, et al
    A health economic simulation model for the clinical management of osteoporosis.
    Osteoporos Int. 2017 Dec 1. pii: 10.1007/s00198-017-4325.
    PubMed     Abstract available


    November 2017
  449. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed    


  450. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed    


  451. NOGUES X, Nolla JM, Casado E, Jodar E, et al
    Spanish consensus on treat to target for osteoporosis.
    Osteoporos Int. 2017 Nov 24. pii: 10.1007/s00198-017-4310.
    PubMed     Abstract available


  452. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Abstract available


  453. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Abstract available


  454. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Abstract available


  455. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Osteoporos Int. 2017 Nov 20. doi: 10.1007/s00198-017-4305.
    PubMed     Abstract available


  456. MAKITIE RE, Niinimaki R, Kakko S, Honkanen T, et al
    Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4309.
    PubMed     Abstract available


  457. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Abstract available


  458. SCHONENBERG D, Guggenberger R, Frey D, Pape HC, et al
    CT-based evaluation of volumetric bone density in fragility fractures of the pelvis-a matched case-control analysis.
    Osteoporos Int. 2017 Nov 13. doi: 10.1007/s00198-017-4307.
    PubMed     Abstract available


  459. CHENBHANICH J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, et al
    Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4295.
    PubMed     Abstract available


  460. MODI A, Sen S, Adachi JD, Adami S, et al
    The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4271.
    PubMed     Abstract available


  461. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Abstract available


  462. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Abstract available


    October 2017
  463. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Abstract available


  464. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Abstract available


  465. RUPPERT K, Cauley J, Lian Y, Zgibor JC, et al
    The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4276.
    PubMed     Abstract available


  466. SPIERINGS J, Bours S, Peeters HRM
    A case of regional migratory osteoporosis.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4240.
    PubMed     Abstract available


  467. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Abstract available


  468. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Abstract available


  469. DUNN P, Webb D, Olenginski TP
    Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4270.
    PubMed     Abstract available


  470. DONG XL, Yu WX, Li CM, He S, et al
    Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4254.
    PubMed     Abstract available


  471. AHN SH, Seo DH, Kim SH, Nam MS, et al
    The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Osteoporos Int. 2017 Oct 19. doi: 10.1007/s00198-017-4257.
    PubMed     Abstract available


  472. KASTNER M, Perrier L, Munce SEP, Adhihetty CC, et al
    Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 18. doi: 10.1007/s00198-017-4248.
    PubMed     Abstract available


  473. MALMGREN L, McGuigan F, Christensson A, Akesson KE, et al
    Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.
    Osteoporos Int. 2017 Oct 16. doi: 10.1007/s00198-017-4221.
    PubMed     Abstract available


  474. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Abstract available


  475. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Abstract available


  476. MALLUCHE HH, Monier-Faugere MC, Blomquist G, Davenport DL, et al
    Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4228.
    PubMed     Abstract available


  477. TSENG OL, Dawes MG, Spinelli JJ, Gotay CC, et al
    Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4218.
    PubMed     Abstract available


  478. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed    


  479. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed    


  480. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Abstract available


  481. ZANCHETTA MB, Boailchuk J, Massari F, Silveira F, et al
    Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4242.
    PubMed     Abstract available


  482. MACK DE, Wilson PM, Santos E, Brooks K, et al
    Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4249.
    PubMed     Abstract available


  483. DALLA VIA J, Daly RM, Fraser SF
    The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4237.
    PubMed     Abstract available


    September 2017
  484. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Abstract available


  485. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Abstract available


  486. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Abstract available


  487. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
    Osteoporos Int. 2017 Sep 21. doi: 10.1007/s00198-017-4207.
    PubMed     Abstract available


  488. LARSEN AU, Grimnes G, Jorde R
    The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes.
    Osteoporos Int. 2017 Sep 18. doi: 10.1007/s00198-017-4222.
    PubMed     Abstract available


  489. BRIOT K, Geusens P, Em Bultink I, Lems WF, et al
    Inflammatory diseases and bone fragility.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189.
    PubMed     Abstract available


  490. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Abstract available


  491. NGUYEN VT, Edmonds SW, Lou Y, Roblin DW, et al
    Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.
    Osteoporos Int. 2017 Sep 7. doi: 10.1007/s00198-017-4204.
    PubMed     Abstract available


  492. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4210.
    PubMed    


  493. LAROCHE M, Talibart M, Cormier C, Roux C, et al
    Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4165.
    PubMed     Abstract available


  494. ROTHMANN MJ, Moller S, Holmberg T, Hojberg M, et al
    Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4205.
    PubMed     Abstract available


  495. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Abstract available


  496. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Abstract available


  497. CELLI M, D'Eufemia P, Persiani P, Turchetti A, et al
    Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporos Int. 2017 Sep 2. doi: 10.1007/s00198-017-4214.
    PubMed     Abstract available


    August 2017
  498. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Abstract available


  499. ROUX C, Baron G, Briot K, Roux B, et al
    Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.
    Osteoporos Int. 2017 Aug 29. doi: 10.1007/s00198-017-4188.
    PubMed     Abstract available


  500. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Abstract available


  501. MIYAKOSHI N, Kudo D, Hongo M, Kasukawa Y, et al
    Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4184.
    PubMed     Abstract available


  502. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed    


  503. JOHANSSON H, Azizieh F, Al Ali N, Alessa T, et al
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4160.
    PubMed     Abstract available


  504. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Abstract available


    July 2017
  505. CHOU L, Shamdasani P, Briggs AM, Cicuttini FM, et al
    Systematic scoping review of patients' perceived needs of health services for osteoporosis.
    Osteoporos Int. 2017 Jul 31. doi: 10.1007/s00198-017-4167.
    PubMed     Abstract available


  506. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Abstract available


  507. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Abstract available


  508. KAMPE AJ, Costantini A, Makitie RE, Jantti N, et al
    PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4150.
    PubMed     Abstract available


  509. MCCLUNG MR, Lippuner K, Brandi ML, Zanchetta JR, et al
    Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140.
    PubMed     Abstract available


  510. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Abstract available


  511. ZENG Y, Zhang L, Zhu W, He H, et al
    Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.
    Osteoporos Int. 2017 Jul 24. doi: 10.1007/s00198-017-4146.
    PubMed     Abstract available


  512. POP LM, Lingvay I, Yuan Q, Li X, et al
    Impact of pioglitazone on bone mineral density and bone marrow fat content.
    Osteoporos Int. 2017 Jul 22. doi: 10.1007/s00198-017-4164.
    PubMed     Abstract available


  513. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Abstract available


  514. REYES C, Tebe C, Martinez-Laguna D, Ali MS, et al
    One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
    Osteoporos Int. 2017 Jul 16. doi: 10.1007/s00198-017-4144.
    PubMed     Abstract available


  515. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed    


  516. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed    


  517. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Abstract available


  518. SHI L, Gao F, Sun W, Wang B, et al
    Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4136.
    PubMed     Abstract available


  519. NGUYEN VH
    Osteoporosis exercise knowledge and education in medicine and nursing.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4119.
    PubMed    


  520. GIANGREGORIO L, Clark R, McArthur C, Papaioannou A, et al
    Osteoporosis exercise knowledge and education in medicine and nursing: response to comments by Nguyen.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4121.
    PubMed    


  521. XUE F, Goli V, Petraro P, McMullan T, et al
    Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4129.
    PubMed     Abstract available


  522. CARFI A, Liperoti R, Fusco D, Giovannini S, et al
    Bone mineral density in adults with Down syndrome.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4133.
    PubMed     Abstract available


  523. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Abstract available



  524. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2017;28.
    PubMed    



  525. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Author Index.
    Osteoporos Int. 2017;28.
    PubMed    



  526. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): ESCEO Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  527. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Meet-the-Experts Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  528. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Plenary Lectures Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  529. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Honorary Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  530. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Oral Communication Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  531. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Satellite Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  532. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Educational Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  533. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  534. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Committee of National Societies Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  535. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): World Health Organization (WHO) Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    



  536. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Poster Abstracts.
    Osteoporos Int. 2017;28.
    PubMed    


    June 2017
  537. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Abstract available


  538. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Jun 28. doi: 10.1007/s00198-017-4100.
    PubMed     Abstract available


  539. AMORIM T, Koutedakis Y, Nevill A, Wyon M, et al
    Bone mineral density in vocational and professional ballet dancers.
    Osteoporos Int. 2017 Jun 27. doi: 10.1007/s00198-017-4130.
    PubMed     Abstract available


  540. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Abstract available


  541. LOGAN S, Thu WPP, Lay WK, Wang LY, et al
    Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4095.
    PubMed     Abstract available


  542. KURODA T, Ohta H, Onoe Y, Tsugawa N, et al
    Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population.
    Osteoporos Int. 2017 Jun 23. doi: 10.1007/s00198-017-4128.
    PubMed     Abstract available


  543. MODI A, Sen S, Adachi JD, Adami S, et al
    Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Osteoporos Int. 2017 Jun 22. doi: 10.1007/s00198-017-4116.
    PubMed     Abstract available


  544. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Abstract available


  545. LV F, Ma M, Liu W, Xu X, et al
    A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Osteoporos Int. 2017 Jun 16. doi: 10.1007/s00198-017-4094.
    PubMed     Abstract available


  546. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Abstract available


  547. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4105.
    PubMed    


  548. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4091.
    PubMed     Abstract available


  549. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Abstract available


  550. BLANCO E, Burrows R, Reyes M, Lozoff B, et al
    Breastfeeding as the sole source of milk for 6 months and adolescent bone mineral density.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4106.
    PubMed     Abstract available


  551. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed    


  552. SHIEK AHMAD B, Petty SJ, Gorelik A, O'Brien TJ, et al
    Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4098.
    PubMed     Abstract available


  553. COULSON J, Bagley L, Barnouin Y, Bradburn S, et al
    Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Osteoporos Int. 2017 Jun 5. doi: 10.1007/s00198-017-4104.
    PubMed     Abstract available


  554. GIFRE L, Ruiz-Gaspa S, Carrasco JL, Portell E, et al
    Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Osteoporos Int. 2017 Jun 4. doi: 10.1007/s00198-017-4090.
    PubMed     Abstract available


  555. SHAH VN, Harrall KK, Shah CS, Gallo TL, et al
    Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.
    Osteoporos Int. 2017 Jun 3. doi: 10.1007/s00198-017-4097.
    PubMed     Abstract available


  556. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed    


    May 2017
  557. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Abstract available


  558. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4073.
    PubMed     Abstract available


  559. UEBELHART B, Rizzoli R, Ferrari SL
    Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4080.
    PubMed     Abstract available


  560. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Abstract available


  561. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, et al
    Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Osteoporos Int. 2017 May 11. doi: 10.1007/s00198-017-4065.
    PubMed     Abstract available


  562. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Abstract available


  563. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Abstract available


  564. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Abstract available


  565. LAIRD E, Molloy AM, McNulty H, Ward M, et al
    Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.
    Osteoporos Int. 2017 May 1. doi: 10.1007/s00198-017-4049.
    PubMed     Abstract available


  566. LEE JH, Kim JH, Hong AR, Kim SW, et al
    Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Osteoporos Int. 2017;28:1667-1674.
    PubMed     Abstract available


  567. ZHOU L, Song J, Yang S, Meng S, et al
    Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
    Osteoporos Int. 2017;28:1693-1698.
    PubMed     Abstract available


  568. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Abstract available


    April 2017
  569. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Abstract available


  570. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRO
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4063.
    PubMed     Abstract available


  571. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed    


  572. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Abstract available


  573. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Abstract available


  574. GUAN Y, Lv F, Meng Y, Ma D, et al
    Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Osteoporos Int. 2017 Apr 24. doi: 10.1007/s00198-017-4041.
    PubMed     Abstract available


  575. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Abstract available


  576. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Abstract available


  577. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Abstract available


  578. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Abstract available


  579. RODRIGUEZ AJ, Scott D, Hodge A, English DR, et al
    Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4024.
    PubMed     Abstract available


    March 2017
  580. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2017 Mar 27. doi: 10.1007/s00198-017-4004.
    PubMed     Abstract available


  581. WU J, Xu L, Lv Y, Dong L, et al
    Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3993.
    PubMed     Abstract available


  582. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Abstract available


  583. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed    


  584. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Abstract available


  585. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Abstract available


  586. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Abstract available


  587. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Abstract available


  588. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Abstract available


  589. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Abstract available


  590. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Abstract available


  591. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed    


  592. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed    


  593. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Abstract available


  594. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Abstract available


  595. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Abstract available


  596. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Abstract available


  597. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Abstract available


  598. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Abstract available


    February 2017
  599. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Abstract available


  600. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Abstract available


  601. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Abstract available


  602. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Abstract available


  603. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Abstract available


  604. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed    


  605. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Abstract available


  606. MARQUES ID, Araujo MJ, Graciolli FG, Reis LM, et al
    Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3956.
    PubMed     Abstract available


  607. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Abstract available


  608. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed    


  609. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed    


  610. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Abstract available


  611. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Abstract available


  612. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Abstract available


  613. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Abstract available


  614. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Abstract available


    January 2017
  615. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed    


  616. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed    


  617. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Abstract available


  618. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Abstract available


  619. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Abstract available


  620. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Abstract available


  621. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Abstract available


  622. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Abstract available


  623. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Abstract available


  624. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Abstract available


    December 2016
  625. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Abstract available


  626. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Abstract available


  627. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  628. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  629. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  630. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed    


  631. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed    


  632. JUHASZ B, Gulyas K, Horvath A, Petho Z, et al
    Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  633. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  634. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  635. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  636. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Abstract available


  637. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  638. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed    


  639. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed    


  640. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  641. DIVASTA AD, Feldman HA, Rubin CT, Gallagher JS, et al
    The ability of low-magnitude mechanical signals to normalize bone turnover in adolescents hospitalized for anorexia nervosa.
    Osteoporos Int. 2016.
    PubMed     Abstract available


    November 2016
  642. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  643. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  644. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  645. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  646. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  647. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  648. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  649. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  650. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  651. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  652. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  653. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  654. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Abstract available



  655. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed    



  656. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed    



  657. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed    



  658. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed    



  659. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed    


    October 2016
  660. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  661. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  662. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  663. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed    


  664. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Abstract available


  665. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  666. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  667. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  668. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  669. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  670. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  671. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  672. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  673. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  674. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  675. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  676. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  677. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Abstract available


    September 2016
  678. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  679. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  680. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed    


  681. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  682. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  683. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed    


  684. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  685. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  686. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  687. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Abstract available


  688. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


    July 2016
  689. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Abstract available


    June 2016
  690. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Abstract available


    May 2016
  691. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  692. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Abstract available


  693. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed    


  694. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Abstract available


  695. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Abstract available


    April 2016
  696. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Abstract available


  697. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Abstract available


  698. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Abstract available


    March 2016
  699. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  700. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Abstract available


  701. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Abstract available


  702. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Abstract available


  703. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Abstract available


  704. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Abstract available


    February 2016
  705. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  706. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Abstract available


  707. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Abstract available


  708. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Abstract available


  709. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Abstract available


  710. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Abstract available


  711. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Abstract available


    January 2016
  712. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Abstract available


  713. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Abstract available


  714. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Abstract available


  715. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Abstract available


    December 2015
  716. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  717. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Abstract available


    November 2015
  718. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  719. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  720. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Abstract available


    October 2015
  721. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  722. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Abstract available


    August 2015
  723. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  724. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  725. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Abstract available


  726. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: